The Activity of Ribavirin against the Human Immunodeficiency Virus: A Review of Laboratory and Clinical Experience

Allen L. , and Fingel C. (1977) Failure of Type I Herpes virus to develop resistance to ribavirin. Antimicrob Agents Chemother 12: 120–121.

Arena A. Merendino R. Liberto M. Mancuso G. Bonina L. , and Mastroeni P. (1987) Combined effects of ribavirin and mononuclear phagocytic cells on virus replication. Int J Immunother 3: 313–317.

Baba M. Pauwels R. Balzarini J. Herdewijn P. De Clerq E. , and Desmyter J. (1987) Ribavirin antagonises inhibitory effects of pyrimidine 2′,3′-dideoxynucleosides but enhances inhibitory effects of purine 2′,3′-dideoxynucleoside on replication of human immunodeficiency virus in vitro. Antimicrob Agents Chemother 31: 1613–1617.

Balzarini J. Mitsuya H. De Clerq E. , and Broder S. (1986) Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/Lymphadenopathy-associated virus (LAV). Int J Cancer 37: 451–457.

Balzarini J. Naesens L. Robins M. , and De Clerq E. (1990) Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2′,3′-dideoxyinosine and 2′,3′-dideoxy-2,6-diaminopurine riboside. J AIDS 3: 1140–1147.

Blanche S. Fischer A. le Deist F. Griscelli C. Guetard D. Favier V. , and Montagnier L. (1986) Ribavirin in HTLV III/LAV infection of infants. Lancet i: 863.

Boucher C. Tersmette M. Lange J. Kellan P. de Goede R. Mulder J. Darby G. Goudsmit J. , and Larder B. (1990) Zidovudine sensitivity of Human Immunodeficiency Viruses from high-risk, symptom-free individuals during therapy. Lancet i: 585–590.

Canonico P. Kastello M. Spears C. Brown J. Jackson E. , and Jenkins D. (1984) Effects of ribavirin on red blood cells. Toxicol Appl Pharmacol 74: 155–162.

Cassidy L. , and Patterson J. (1989) Mechanism of La Crosse virus inhibition by ribavirin. Antimicrob Agents Chemother 33: 2009–2011.

Civitico G. Wang Y. Luscombe C. Bishop N. Tachedjian G. Gust I. , and Locarnini S. (1990) Antiviral strategies in chronic Hepatitis B virus infection. J Med Virol 31: 90–97.

Crocchiolo P. Pristera R. Lazzarin A. Chemotti M. Froldi M. Palazzini E. Verani P. Orecchia A. , and Moroni M. (1989) A trial with ribavirin in patients with AIDS or AIDS-related complex. Boll 1st Sieroter Milan 68: 185–190.

Crumpacker C. Bubley G. Lucey D. Hussey S. , and Connor J. (1986) Ribavirin enters cerebrospinal fluid. Lancet ii: 45–46.

Crumpacker C. Heagy W. Bubley G. Monroe J. Finberg R. Hussey S. Schnipper L. Lucey D. Lee T. McLane M. Essex M. , and Mulder C. (1987) Ribavirin treatment of AIDS and AIDS-related complex. Ann Intern Med 107: 664–674.

Eriksson B. Helgstrand E. Johansson N. Larsson A. Misiorny A. Noren J. Philipson L. Stenberg K. Stening G. Stridh S. , and Oberg B. (1977) Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother 11: 946–951.

Fernandez H. Banks G. , and Smith R. (1986) Ribavirin: a clinical overview. Eur J Epidemiol 2: 1–14.

Fernandez-Larsson R. , and Patterson J. (1990) Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase. Mol Pharmacol 38: 766–770.

Fischl M. Richman D. Grieco M. Gottlieb M. Volberding P. Laskin O. Leedom J. Groopman J. Mildvan D. Schooley R. Jackson G. Durack D. , King, D., and the AZT collaborative working group (1987) The efficacy of azidothymidine in the treatment of patients with AIDS and AIDS-relating complex. N Engl J Med 317: 185–191.

Funke I. Hahn A. Rieber E. Weiss E. , and Reithmuller G. (1987) The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. J Exp Med 165: 1230–1235.

Gilbert B. , and Knight V. (1990) Ribavirin aerosol as the treatment for influenza. Drugs Today 26: 195–205.

Goswami B. Borek E. Sharma O. Fujitaki J. , and Smith R. (1979) The broad-spectrum antiviral agent ribavirin inhibits capping of mRNA, Biochem Biophys Res Comm 89: 830–836.

Hall C. McBride J. Walsh E. Bell D. Gala C. Hildreth S. ten Eyck L. , and Hall W. (1983) Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection. N Engl J Med 308: 1443–1447.

Huggins J. (1989) Prospects for treatment of viral haemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis 11 (suppl. 4): S750–S761.

Johnson E. (1990) The effects of ribavirin on development and reproduction: a critical review of published and unpublished studies in experimental animals. J Amer Coll Toxicol 9: 551–561.

Jolley W. , and Suchil C. (1984) Effects of ribavirin on the immune system (second report). In: Clinical Applications of Ribavirin (eds Smith R. Knight V. , and Smith J. ), pp. 93–96. Academic Press, London.

Kennedy P. Scolaro M. , and Blayney D. (1989) Failure of combined antiviral and immune modulation therapy to alter clinical and biological parameters in AIDS. Proc ASCO 8: 5.

Kramer T. Gaar G. Ray C. Minnich L. Copeland J. , and Connor J. (1990) Haemodialysis clearance of intravenously administered ribavirin. Antimicrob Agents Chemother 34: 489–490.

L'Abbé K. Detsky A. , and O'Rourke K. (1987) Meta-analysis in clinical research. Ann Intern Med 107: 224–233.

McCormick J. Getchell J. Mitchell S. , and Hicks D. (1984) Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet ii: 1367–1369.

McCormick J. King I. Webb P. Scribner C. Craven R. Johnson K. Elliott L. , and Belmont-Williams R. (1986) Lassa Fever: Effective therapy with ribavirin. N Engl J Med 314: 20–26.

Malinoski F. , and Strollar V. (1981) Inhibitors of IMP dehydrogenase prevent Sindbis virus replication and reduce GTP levels in Aedes albopictus cells. Virology 110: 281–291.

Montefiori D. Robinson W. , and Mitchell W. (1989) In vitro evaluation of mismatched double-stranded RNA (Ampligen) for combination therapy in the treatment of AIDS. AIDS Res Hum Retrovir 5: 193–203.

Morrison S. Connor E. Denny T. Schnell J. Niven P. Skuza K. Connor J. Lane J. , and Oleska J. (1988) Preliminary data from a phase I study of intravenous and oral ribavirin in symptomatic HIV-infected children. Pediatr Res 23: 358A.

Oberg B. , and Helgstrand E. (1977) Selective inhibition of viral polymerases by ribavirin triphosphate. In: Proc 10th Intl Congr Chemother, Zurich 1977 (eds Seigenthaler W. , and Luthy R. ). Curr Chemother 1: 332–334.

Page T. , and Connor J. (1990) The metabolism of ribavirin in erythrocytes and nucleated cells. Int J Biochem 22: 379–383.

Paroni R. del Puppo M. Borghi C. Sirtori C. , and Kienle M. Galli (1989) Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers. Int J Clin Pharmacol Exp Ther 27: 302–307.

Patterson J. , and Fernandez-Larsson R. (1990) Molecular mechanism of action of ribavirin. Rev Infect Dis 12: 1139–1146.

Price R. Brew B. Sistis J. Rosenblum M. Scheck A. , and Cleary P. (1988) The brain in AIDS: central nervous system HIV-I infection and AIDS dementia complex. Science 239: 586–592.

Pristera R. Marchesi M. Vedovelli C. Moling O. Poluselli P. Fauri I. , and Palazzini E. (1989) Treatment of HIV-related PGL and LAS patients with ribavirin and thymopentine versus control patients. Giorn Mal Infett Parassit 41: 550–552.

Reichard O. Andersson J. Schvarcz R. , and Wealand O. (1991) Ribavirin: treatment for chronic Hepatitis C. Lancet i: 1058–1061.

Ribavirin ARC Study Group. (1991) Multicenter clinical trial of oral ribavirin in symptomatic HIV-infected patients. J AIDS (in press).

Roberts R. , and Laskin O. (1988) Phase I clinical studies of ribavirin in high risk patients for the acquired immunodeficiency syndrome. In: HIV and Other Highly Pathogenic Viruses (ed. Smith R. ), pp. 95–112. Academic Press, San Diego.

Roberts R. Dickinson G. Heseltine P. Leedom J. Mansell P. Rodriguez S. Johnson K. Lubina J. , Makuch, R., and the Ribavirin-LAS Collaborative Group. (1990a) A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. J AIDS 3: 884–892.

Roberts R. Hollinger F. Parks W. Rasheed S. Lawrence J. Heseltine P. Makuch R. Lubina J. , Johnson, K., and the Ribavirin-LAS Collaborative Group. (1990b) A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. AIDS 4: 67–72.

Roberts R. Jurica K. Meyer W. Paxton H. , and Makuch R. (1990c) A Phase I study of ribavirin in HIV-infected patients. J Infect Dis 162: 638–642.

Rodriguez W. , and Parrott R. (1987) Ribavirin aerosol treatment of serious respiratory syncytial virus infection in infants. Infect Dis Clin N America 1: 425–439.

Illescas R. Ruiz Romero M. Fuentes J. Colin Carreon F. Rivera Arana J. Salaza , and Uscanga R. Romero (1988) Usefulness of ribavirin in the treatment of the patient with acquired immunodeficiency. Med Intern Mexico 4: 128.

Schulof R. Parenti D. Simon G. Paxton H. Meyer W. Schlesselman S. Courtless J. LeLacheur S. , and Sztein M. (1990) Clinical, virologic, and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men. J AIDS 3: 485–492.

Schwartz O. Henin Y. Marechal V. , and Montagnier L. (1988) A rapid and simple colorimetric test for the study of anti-HIV agents. AIDS Res Hum Retrovir 4: 441–448.

Sidwell R. Revankar G. , and Robins R. (1985) Ribavirin: review of a broad-spectrum antiviral agent. In: International Encyclopedia of Pharmacology and Therapeutics Section 116; Viral Chemotherapy, Vol. 2 (ed. Shugar D. ), pp. 49–108. Pergamon Press, Oxford.

Spanish Ribavirin Trial Group. (1991) Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection. Lancet ii: 6–9.

Spector S. Kennedy C. McCutchan J. Bozzette S. Struabe R. Connor J. , and Richman D. (1989) The antiviral effect of zidovudine and ribavirin in clinical trials and the use of P24 antigen levels as a virologic marker. J Infect Dis 159: 822–828.

Steele R. Crosby D. Steele R. Pilkington N. Charlton R. (1988) Effects of ribavirin on neutrophil function. Am J Med Sci 295: 503–506.

Vogt M. , and Hirsch M. (1987) Treatment of human immunodeficiency virus infections. Infect Dis Clin N America 1: 323–329.

Vogt M. Hartshorn K. Furman P. Chou T.-C. Fyfe J. Coleman L. Crumpacker C. Schooley R. , and Hirsch M. (1987) Ribavirin antagonises the effect of azidothymidine on HIV replication. Science 235: 1376–1379.